Scientists Identify a Metabolic Pathway Linked to Lung Cancer Spread to Lymph Nodes

Lung cancer can spread beyond the lungs through the lymphatic system and bloodstream. Lymph-node involvement is an important factor in determining cancer stage, treatment planning and prognosis.

Researchers are investigating how cancer cells alter their metabolism to survive, move through surrounding tissue and establish secondary tumours.

The newly reported study examined MOCCI, a protein associated with mitochondrial complex IV. Mitochondria are cellular structures responsible for producing much of the energy required by cells.

The researchers found that MOCCI was associated with changes in oxidative phosphorylation, a process involved in cellular energy production. In laboratory experiments, reducing MOCCI expression decreased cancer-cell migration and invasion by more than 50%, while increasing its expression enhanced several processes associated with tumour spread.

The work provides insight into how mitochondrial metabolism may contribute to lung cancer progression. It could help identify possible molecular targets for future treatment research.

However, the findings come from laboratory and animal experiments. They do not establish an effective treatment for people with lung cancer, and further research is required before clinical applications can be considered.